Mark Mansfield
Mark Mansfield
Send Message
Mark Mansfield
Stop FollowingMark Mansfield
View as an RSS Feed
- Ryder Systems: Solid - Yet Overlooked - Transportation Company
- Why I Think Deere Is a Buy Ahead of Earnings
- Human Genome: Buy the Pipeline Before Glaxo Does
- Why Molycorp Is a Buy Despite Its Sticker Price
- Why I'm Maintaining My Long Position in Coinstar
- Growing Signs That We May Be on the Verge of a Correction
- Coinstar Slides Again After Earnings Announcement: Is There Still Hope?
- Cigna: Don't Be Alarmed by Soft Guidance
- Delcath Systems Begins to Run Ahead of FDA NDA Response
- A Protected Play on Broadcom
- Orexigen Options: A Lesson in Trading Biotech
- Why I Am Short Caterpillar
- Coinstar: Short-Term Has Only One Direction to Go
- Why Molycorp Is a Short Through Next Week
- Medtronic Drops the Ball on Pacemakers
-
Dangerous Developments in U.S. Creditworthiness
on Tue, Dec 7, 2010 • 18 Comments
- Why I See the Ireland Bailout Failing
- Why Obama's Capital Investment Write-Off Will Do Little
- A Wild Wednesday and a Coming Global Crash?
- 5 Reasons the Bears Brought the Market Down
- Why China's Yuan Revaluation Isn't That Exciting
- A Summation of Bleak Global Economic Evidence
- Bank Liquidity Strains in China?
-
Five Possible Outcomes for Greece
on Thu, Apr 22, 2010 • 4 Comments
- Walter Energy: Overvalued and Overbought
- Matrixx Initiatives: A Critical Test of Crisis Management
